Filing Details

Accession Number:
0000899243-22-037033
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-25 16:25:24
Reporting Period:
2022-11-23
Accepted Time:
2022-11-25 16:25:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1792044 Viatris Inc VTRS Pharmaceutical Preparations (2834) 834364296
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1848812 (Sean) Xiangyang Ni 1000 Mylan Boulevard
Canonsburg PA 15317
President, Greater China No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-23 29,815 $0.00 40,136 No 4 M Direct
Common Stock Acquisiton 2022-11-23 1,829 $0.00 41,965 No 4 M Direct
Common Stock Disposition 2022-11-25 12,800 $10.95 29,165 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2022-11-23 29,815 $0.00 29,815 $0.00
Common Stock Dividend Equivalent Units Disposition 2022-11-23 1,828 $0.00 1,828 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
0 No 4 M Direct
Footnotes
  1. Fractional shares have been rounded up in connection with the settlement described in footnote 4 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
  2. Shares sold to satisfy the tax liability associated with the vesting and settlement of the RSUs granted on November 23, 2020 and the related dividend equivalent units (DEUs).
  3. Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs vested in full on November 23, 2022.
  4. Represents DEUs that accrued with respect to the 29,815 RSUs previously granted on November 23, 2020 and vested on the same schedule as the underlying RSUs.